Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer
Active, not recruiting · NCT04046445 · Registry updated 2025-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 1 | 2025-01-29 | NCT04046445 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amal Therapeutics | 1 |
| Boehringer Ingelheim | 158 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Cancer Institute | Durham | United States | 47 |
| Geneva University Hospitals | Geneva | Switzerland | 10 |
| Honor Health Institute | Scottsdale | United States | 1 |
| NYU Langone Health | New York | United States | 403 |
| University Hospital Antwerpen | Edegem | Belgium | 1 |
| University Hospital Leuven | Leuven | Belgium | 18 |
| University Hospital Zurich | Zurich | Switzerland | 3 |
| University Medicine Mainz | Mainz | Germany | 1 |
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Southern California | Los Angeles | United States | 110 |
| University of Texas, MD Anderson Cancer Center | Houston | United States | 12 |
| Weill Cornell Medicine | New York | United States | 122 |